Cinemark (NYSE:CNK - Get Free Report)'s stock had its "outperform" rating reiterated by investment analysts at Barrington Research in a report released on Wednesday,Benzinga reports. They presently have a $40.00 target price on the stock. Barrington Research's price objective would suggest a potential upside of 45.60% from the stock's previous close. Barrington Research also issued estimates for Cinemark's Q2 2025 earnings at $0.49 EPS, Q3 2025 earnings at $0.53 EPS, Q1 2026 earnings at $0.09 EPS, Q3 2026 earnings at $0.71 EPS and FY2027 earnings at $2.09 EPS.
Other equities research analysts also recently issued research reports about the stock. JPMorgan Chase & Co. raised their price target on shares of Cinemark from $29.00 to $31.00 and gave the company a "neutral" rating in a research report on Thursday, January 30th. Wedbush reissued a "neutral" rating and set a $32.00 price target on shares of Cinemark in a research report on Tuesday. Wells Fargo & Company reduced their price target on shares of Cinemark from $38.00 to $36.00 and set an "overweight" rating for the company in a research report on Wednesday, January 29th. Macquarie raised their price target on shares of Cinemark from $32.00 to $34.00 and gave the company an "outperform" rating in a research report on Friday, November 1st. Finally, Benchmark reissued a "buy" rating and set a $40.00 price target on shares of Cinemark in a research report on Friday, January 10th. One analyst has rated the stock with a sell rating, four have given a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $32.70.
View Our Latest Report on Cinemark
Cinemark Stock Down 1.1 %
Shares of NYSE CNK traded down $0.32 on Wednesday, reaching $27.47. 4,297,576 shares of the company's stock traded hands, compared to its average volume of 2,861,287. Cinemark has a 12 month low of $15.74 and a 12 month high of $36.28. The business's 50 day simple moving average is $30.33 and its two-hundred day simple moving average is $29.75. The company has a market cap of $3.36 billion, a price-to-earnings ratio of 13.53 and a beta of 2.38. The company has a quick ratio of 0.96, a current ratio of 0.98 and a debt-to-equity ratio of 3.87.
Cinemark (NYSE:CNK - Get Free Report) last announced its earnings results on Wednesday, February 19th. The company reported $0.33 earnings per share for the quarter, missing analysts' consensus estimates of $0.39 by ($0.06). Cinemark had a net margin of 10.16% and a return on equity of 65.83%. The business had revenue of $814.30 million for the quarter, compared to the consensus estimate of $797.18 million. During the same period in the prior year, the business posted ($0.15) EPS. Cinemark's revenue for the quarter was up 27.5% on a year-over-year basis. As a group, equities research analysts forecast that Cinemark will post 1.98 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. Mackenzie Financial Corp purchased a new position in shares of Cinemark during the 4th quarter worth $221,000. Elequin Capital LP boosted its stake in shares of Cinemark by 211.6% during the 4th quarter. Elequin Capital LP now owns 997 shares of the company's stock worth $31,000 after acquiring an additional 677 shares during the last quarter. PharVision Advisers LLC purchased a new position in shares of Cinemark during the 4th quarter worth $277,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Cinemark by 24.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 319,768 shares of the company's stock worth $9,906,000 after acquiring an additional 61,911 shares during the last quarter. Finally, Voloridge Investment Management LLC purchased a new position in shares of Cinemark during the 4th quarter worth $8,317,000.
Cinemark Company Profile
(
Get Free Report)
Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.
Further Reading

Before you consider Cinemark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cinemark wasn't on the list.
While Cinemark currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.